Description générale
Atropine is a muscarinic antagonist with multiple therapeutic indications including reduction of salivary and bronchial secretions during surgical procedures, treatment of organophosphate poisoning, and as a cycloplegic and mydriatic agent following topical administration into the eye.
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 1977
(TRS
615)
pour
Exposure to or harmful effects of undetermined intent of pesticides
Ajouté en 1987
(TRS
770)
pour
Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
Ajouté en 1989
(TRS
796)
pour
Anterior uveitis
Modifié en 2021
(TRS
1035)
pour
Cycloplegic drug
Équivalent thérapeutique pour
Wikipédia
DrugBank
Recommandations
Section
Preoperative medication and sedation for short-term procedures
- Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (atropine sulfate)
Section
Antidotes and other substances used in poisonings > Specific
- Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (atropine sulfate)
Section
Ophthalmological preparations > Mydriatics
- Local > Ophthalmological > Solution (eye drops): 0.1% (sulfate); 0.5% (sulfate); 1% (sulfate)
Indications